Background and objectives of ABCD-UKKA committee
Diabetic kidney disease (DKD) is one of the leading causes of chronic kidney disease, end stage kidney disease in the United Kingdom (UK) and globally. DKD is also a risk factor for premature morbidity and mortality often related to the very high risk of cardiovascular disease.
The joint ABCD-UKKA committee seeks to improve the care of people with diabetic kidney disease (DKD) by the following actions: Creation and regular updating of treatment guidelines, with a specific focus on the National Health Service (NHS) and medicines licensed for use in the UK promotion of the use of these treatment guidelines by the clinical community.
The committee supports medical and non-medical trainees in renal/kidney medicine and Diabetes/Endocrinology to ensure a thorough grounding in the other specialty and knowledge of joint working. One of the key tasks of the committee is the organisation of a joint ABCD-UKKA conference held every two years in the UK. The committee also provides expert input into consultations on DKD e.g. those of the National Institute for Health and Care Excellence (NICE) and expert comment on service delivery and development for people with DKD. In parallel to the above ABCD UKKA committee provides expert advice on priorities for research and audit in DKD and supports in delivering educational symposia on DKD at meetings of other specialist societies
History of ABCD UKKA committee
The group was co-founded by Dr Peter Winocour after meetings with Prof David Wheeler and Dr Andrew Frankel, The objective was to improve co-ordinated care through the production of joint guidelines and through specialist education. The inaugural ABCD UKKA meeting was held in Birmingham in May 2012 and since then have had our 7th meetings the most recent in 2025. Past co-Chairs of the group include Prof Steve Bain and Prof Indranil Dasgupta. The group has produced multiple clinical guidelines as well as delivered education at several regional and national conferences, UK Diabetes and Renal specialist training days on the subject of diabetic kidney disease nationally. The group is composed multidisciplinary health care professionals working in the UK with a clinical focus, experience and expertise in DKD.
Recent peer reviewed published clinical guidelines by the group
Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD
https://pubmed.ncbi.nlm.nih.gov/41141497/
Finerenone in the management of diabetes kidney disease
https://pubmed.ncbi.nlm.nih.gov/39923037/
Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines
https://pubmed.ncbi.nlm.nih.gov/39415639/
Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024
https://pubmed.ncbi.nlm.nih.gov/38971750/
Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis
https://pubmed.ncbi.nlm.nih.gov/37069983/
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease
https://pubmed.ncbi.nlm.nih.gov/35080257/
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation
https://pubmed.ncbi.nlm.nih.gov/33434362/
Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021
https://pubmed.ncbi.nlm.nih.gov/35497783/
